✦ LIBER ✦

Long-term lamivudine treatment in anti-HBe positive chronic hepatitis B: an interim analysis

✍ Scribed by T. Santantonio; E. Sinisi; M. Mazzola; M. Insalata; A. Guastadisegni; G. Pastore

Book ID: 119527312
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 268 KB
Volume: 34
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(01)81357-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon/long-term lamivudine combinat

Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients

✍ NIKOLAOS L NIKOLAIDIS; OLGA I GIOULEME; KONSTANTINOS A TZIOMALOS; ADAMOS S SAVER 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Lamivudine therapy in patients with anti

Lamivudine therapy in patients with anti HBe positive chronic hepatitis B; end of treatment analysis

✍ NC Tassopoulos; R Volpes; G Pastore; J Heathcote; M Buti; R Goldin; S Hawley; DF 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Treatment of chronic hepatitis B anti-HB

Treatment of chronic hepatitis B anti-HBe positive: A long term follow-up

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Lamivudine-resistant HBV mutants in pati

Lamivudine-resistant HBV mutants in patients with anti-HBe positive chronic hepatitis B treated with long-term lamivudine monotherapy

✍ Teresa Santantonio; Emanuele Sinisi; Maria Insalata; Emilio Palumbo; Angela Guas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Lamivudine and lamivudine plus interfero

Lamivudine and lamivudine plus interferon treatment in naive anti-hbe positive patients with chronic hepatitis B

✍ U.S. Akarca; G. Ersoz; F. Gunsar; N. Kilicsoy; Z. Karasu; R. Vardar; Y. Batur 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Long-term follow-up of anti-HBe-positive

Long-term follow-up of anti-HBe-positive chronic active hepatitis B

✍ Giovanna Fattovich; Lucio Brollo; Alfredo Alberti; Patrizia Pontisso; Giuliano G 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

Twenty-eight patients with chronic active hepatitis without cirrhosis who were positive for hepatitis B surface antigen and antibody to hepatitis B e antigen were followed for 1 to 15 years (mean 6.6 years) and underwent follow-up biopsy. At presentation, 12 of the 28 patients (43%) had hepatitis B